The American Pharmacists Association joined NCPA as an equal partner in a federal lawsuit challenging retroactive fees imposed on pharmacies and, indirectly, their patients. “HHS has acknowledged on multiple occasions that retroactive pharmacy DIR fees inflict harm on pharmacies and increase costs for their patients, but it has repeatedly neglected to address the problem,” said APhA Executive Vice President and CEO Scott J. Knoer. NCPA CEO Douglas Hoey agreed. “Independent pharmacies are buckling under the weight of pharmacy DIR fees, and we’ve been fighting them for years in Congress, the regulatory agencies, and now the courts … We cannot let this go on any longer.” Read the press release here.
NCPA
